Tuesday, 20 March 2018 - 14:52
  • it
  • de
  • en
  • fr


An analysis of Italian multinational Menarini

Milano Finanza has published a long article about the Italy-based multinational Menarini, which has grown at higher rates than the pharmaceutical industry’s average over the last years. The group, controlled by the holding company Pharmafin, which belongs to the Aleotti…

Menarini’s strategy

Economic-financial daily Il Sole 24 Ore reported a long statement by Menarini chairman Lucia Aleotti, who indicated some guidelines for the growth of the Italy-based pharmaceutical group. The company is determined to pursue an organic growth, yet it doesn’t rule…

Menarini to acquire CellSearch in the US

Menarini has acquired US-based CellSearch CTC from US-based Janssen Diagnostics LLC through its subsidiary Menarini Silicon Biosystems. CellSearch’s portfolio includes the only instrument already approved by FDA and granted the CE mark capable of detecting circulating tumor cells in patients…

Menarini/Chugai license agreement for oncology drug

Chugai Pharmaceutical and Berlin-Chemie Menarini, a company of the Menarini Group, announced they entered into a license agreement for PA799, class I PI3K inhibitor. PA799 is a product of Chugai’s, which has already undergone a Phase I trial for solid…